Entered into a Definitive Merger Agreement
with XTI Aircraft; Transaction Expected to be Completed during
the Fourth Quarter of 2023
Entered into a Definitive Agreement to
Spin-off and Merge Inpixon's SAVES UK Business with Damon
Motors Inc.
Inpixon to Host a Conference Call at
4:30 p.m. Eastern Time Today to
Provide a Business Update and Presentation by Damon Motors
Management
PALO
ALTO, Calif., Nov. 14,
2023 /PRNewswire/ -- Inpixon® (Nasdaq: INPX) today
provided a business update and reported financial results for the
third quarter ended September 30,
2023.
"Over the last year we have been focused on identifying and
executing on strategic opportunities that we believe will drive
value for our shareholders," commented Nadir Ali, CEO of Inpixon. "In this regard, we
made significant progress during the third quarter and over recent
weeks. Specifically, we have entered into two definitive agreements
with innovative transportation companies, both of which we believe
are disruptors within their respective industries. We believe these
transactions will be transformational for Inpixon and our
shareholders, providing the opportunity to be stockholders in two
separate, publicly traded companies, each of which we believe can
provide a meaningful opportunity to maximize shareholder value over
time.
"Our proposed merger with XTI Aircraft Company ("XTI
Aircraft"), an innovative aviation company, is progressing as
anticipated. XTI Aircraft is developing the TriFan 600, a
fixed-wing, vertical lift crossover airplane (VLCA), which has the
potential to revolutionize point-to-point air travel by combining
the comfort, speed, and range of a conventional business aircraft
with the flexibility, convenience, and pinpoint landing ability of
a helicopter. XTI Aircraft currently has over 700
conditional pre-orders1, representing the potential for
gross revenues of more than $7.0 billion2.
Upon completion of the merger, Inpixon is anticipated to be renamed
XTI Aerospace, will trade under the new ticker symbol XTIA, and
will be led by a new senior management team and board of directors.
The S-4 registration statement filed in connection with the XTI
transaction was declared effective by the SEC yesterday, and the
related shareholder meeting has been scheduled for December 8th, 2023. We anticipate closing this
transaction during the fourth quarter of 2023 and will continue to
provide updates as material developments unfold.
"In addition, we recently announced the planned spin-off of
our newly formed subsidiary Grafiti Holding, which will hold our UK
SAVES business, and the proposed subsequent business combination of
Grafiti and Damon Motors Inc. ("Damon"), a British Columbia company, and the maker of the
acclaimed HyperSport electric motorcycle. The Damon HyperSport is
expected to be one of the safest, smartest, and most powerful
motorcycles available in the market, and Damon has already obtained
approximately $85 million in
pre-production consumer reservations for its motorcycles. These
advanced reservation orders demonstrate the high demand for an
innovative motorcycle that combines performance, safety and
sustainability. Upon completion of the merger, Grafiti will
be renamed to a name selected by Damon and Damon's management team
and board of director designees will continue to serve as the
management and board of directors of the combined company, with one
board designee appointed by Grafiti. The registration statement in
connection with the spinoff was confidentially filed with the SEC
yesterday. We expect this transaction to close during the first
quarter of 2024.
"During the third quarter, we also continued transforming our
real-time location system (RTLS) business from one-time sales to
recurring, higher-margin subscription sales, which resulted in
improved gross margin for the quarter. In turn, this should help
drive improved operating results going forward. We incurred
meaningful transaction-related costs associated with the two
transactions, however, we remain focused on carefully managing
expenses. We ended the quarter with over $13.5 million in cash and cash equivalents as of
September 30, 2023. Overall, we are
proud of the progress made to date and encourage all investors and
interested parties to participate in the business update
presentation this afternoon, which will include a recap of
Inpixon's developments as well as an overview of Damon, provided by
its management team," concluded Mr. Ali.
Footnotes:
1 Conditional pre-orders refers to a combination of
aircraft purchase agreements, non-binding reservation deposit
agreements, options and letters of intent from potential
purchasers.
2 Based on XTI's current list price of $10 million per aircraft and assuming XTI is able
to execute on the development program for the
TriFan 600, secure FAA certification, and deliver the
aircraft.
Financial Results
Revenues for the three and nine months ended September 30, 2023, were $2.0 million and $7.2
million, respectively, compared to $2.4 million and $7.7
million, respectively, for the comparable periods in the
prior year. This decrease is primarily attributable to the decrease
in Indoor Intelligence sales due to longer sales cycles. Gross
profit for the three and nine months ended September 30, 2023, was $1.6 million and $5.5
million, respectively, compared to $1.7 million and $5.3
million for the 2022 respective periods. The gross profit
margin for the three and nine months ended September 30, 2023, was 78% and 77%, compared to
69% and 69% for the three and nine months ended September 30, 2022, respectively. This increase
in gross profit margin was primarily due to the lower cost of
revenues on the SAVES and indoor intelligence product
lines.
Operating expenses for the three months ended September 30, 2023 were $10.6 million and $7.1
million for the comparable period ended September 30, 2022. This increase of
approximately $3.5 million is
primarily attributable to the acquisition and transaction costs
incurred in the three months ended September
30, 2023. Operating expenses for the nine months ended
September 30, 2023 were $29.5 million and $25.8
million for the comparable period ended September 30, 2022. This increase of $3.7 million is primarily attributable to the
acquisition costs and transaction costs in the nine months ended
September 30, 2023 offset by the
$2.0 million of goodwill impairment
in the nine months ended September 30,
2022.
Net loss from continuing operations for the three months ended
September 30, 2023 was $10.8 million compared to $10.9 million for the comparable period in the
prior year. Net loss from continuing operations for the nine
months ended September 30, 2023, was
$30.5 million compared to
$27.1 million for the comparable
period in the prior year. Non-GAAP Adjusted EBITDA for the three
and nine months ended September 30,
2023 was a loss of $4.1
million and $14.0 million,
respectively, compared to a loss of $1.4 million and $9.4 million for the prior year periods,
respectively. Non-GAAP Adjusted EBITDA is defined as net income or
loss before interest, provision for income taxes, depreciation and
amortization plus adjustments for other income or expense items,
non-recurring items and non-cash items including stock-based
compensation.
Proforma non-GAAP net loss per basic and diluted common share
for the three and nine months ended September 30, 2023 was a loss of $0.08 and $0.60, respectively, compared to a loss of
$0.84 and $4.78 for the prior year periods. Non-GAAP
net loss per share is defined as net loss per basic and diluted
share adjusted for non-cash items including stock-based
compensation, amortization of intangibles and one-time charges and
other adjustments including impairment of goodwill, unrealized and
realized gains and losses on equity securities, and acquisition
costs.
Conference Call and Presentation Information
Inpixon will host a conference call presentation today at
4:30 p.m. Eastern Time to provide a
business update as well as a presentation by the management of
Damon Motors following the recently announced spin-off and merger
agreement between Inpixon's wholly owned subsidiary, Grafiti
Holding, Inc. and Damon.
Interested parties may access the conference call presentation
at https://www.webcaster4.com/Webcast/Page/2235/49432 or
at the link on Inpixon's Investor Relations section of the
website, ir.inpixon.com/ir-news-events/ir-calendar. A
webcast replay will be available on Inpixon's Investor Relations
section of the website
(ir.inpixon.com/ir-news-events/ir-calendar).
Shareholders and other interested parties are invited to submit
questions to Inpixon management via email
to inpx@crescendo-ir.com.
About Inpixon
Inpixon® (Nasdaq: INPX) is the innovator of Indoor
Intelligence®, delivering actionable insights for
people, places and things. Combining the power of mapping,
positioning and analytics, Inpixon helps to create smarter, safer,
and more secure environments. The company's Indoor Intelligence and
industrial real-time location system (RTLS) solutions are leveraged
by a multitude of industries to optimize operations, increase
productivity, and enhance safety. Inpixon customers can take
advantage of industry leading location awareness, analytics, sensor
fusion, IIoT and the IoT to create exceptional experiences and to
do good with indoor data. For the latest insights, follow Inpixon
on LinkedIn, and X, and visit inpixon.com.
About XTI
XTI Aircraft Company is an aviation business based near
Denver, Colorado. XTI is guided by
a leadership team with decades of experience, deep expertise, and
success bringing new aircraft to market, including more than 40
FAA-certified new aircraft configurations. XTI is founded on a
culture of customer-focused problem solving to meet the evolving
needs of modern travelers. For information and updates about XTI
Aircraft Company and the TriFan 600, visit xtiaircraft.com.
For information on reserving a priority position for the TriFan
under the company's pre-sales program, contact Mr. Saleem Zaheer at +1-720-900-6928 or
szaheer@xtiaircraft.com.
About Damon Motors
Damon Motors is a global technology leader disrupting urban
mobility, led by entrepreneurs and executives from
world-class EV and technology companies. With its offices in
San Rafael, California and
headquartered in Vancouver,
Canada, Damon is on a mission to cause a paradigm shift for
safer, smarter motorcycling. Anchored by its proprietary electric
powertrain, HyperDrive™, Damon has captured the attention of the
motorcycling world by delivering 200 hp, a top speed of 200 mph,
200 miles of range, innovative design, and new safety features,
including CoPilot™ and Shift™, which are attracting an entirely new
generation of motorcycle riders. With strong consumer interest in
the US and abroad, Damon aims to set a new standard for motorcycle
safety and sustainability worldwide. For more information on how
Damon technology is defining the new industry standard, please
visit damon.com.
Non-GAAP Financial Measures
Management believes that certain financial measures not in
accordance with generally accepted accounting principles in
the United States ("GAAP") are
useful measures of operations. EBIDTA, Adjusted EBITDA and pro
forma net loss per share are non-GAAP measures. Inpixon defines
"EBITDA" as net income (loss) before interest, provision for
(benefit from) income taxes, and depreciation and amortization.
Management uses Adjusted EBITDA as a metric for which it manages
the business, and Inpixon defines "Adjusted EBITDA" as EBITDA plus
adjustments for other income or expense items, non-recurring items
and non-cash items. Inpixon defines "pro forma net loss per share"
as GAAP net loss per share adjusted for stock-based compensation,
amortization of intangibles and one-time charges including
impairment of goodwill and gain or loss on equity securities.
Management provides Adjusted EBITDA and pro forma net loss per
share measures so that investors will have the same financial
information that management uses, which may assist investors in
assessing Inpixon's performance on a period-over-period basis.
Adjusted EBITDA or pro forma net loss per share is not a measure of
financial performance under GAAP and should not be considered an
alternative to net income (loss) or any other measure of
performance under GAAP, or to cash flows from operating, investing
or financing activities as an indicator of cash flows or as a
measure of liquidity. Adjusted EBITDA and pro forma net loss per
share have limitations as analytical tools and should not be
considered either in isolation or as a substitute for analysis of
Inpixon's results as reported under GAAP.
For more information on our non-GAAP financial measures and a
reconciliation of GAAP to non-GAAP measures, please see the
"Reconciliation of Non-GAAP Financial Measures" table accompanying
this press release.
Important Information About the Proposed Damon Transaction
and Where to Find It
In connection with the spin-off, Grafiti will file with the SEC
a registration statement, registering Grafiti common shares.
Grafiti will also file a preliminary and final non-offering
prospectus with the British Columbia Securities Commission relating
to the business combination with Damon. This press release does not
contain all the information that should be considered concerning
the spin-off and the business combination with Damon (the "Proposed
Damon Transaction") and is not a substitute for any other documents
that Inpixon or Grafiti may file with the SEC, or that Damon may
send to stockholders in connection with the business combination.
It is not intended to form the basis of any investment decision or
any other decision in respect to the Proposed Damon Transaction.
Damon's stockholders and Inpixon's stockholders and other
interested persons are advised to read, when available, the
registration statement of Grafiti together with its exhibits, as
these materials will contain important information about Inpixon,
Grafiti, Damon, the Proposed Damon Transaction.
The registration statement and other documents to be filed by
Grafiti with the SEC will also be available free of charge, at the
SEC's website at www.sec.gov, or by directing a request to: Grafiti
Holding Inc., 2479 E. Bayshore Road, Suite 195, Palo Alto, CA 94303.
Forward-Looking Statements Regarding the Proposed Damon
Transaction
This press release contains certain "forward-looking statements"
within the meaning of the United States Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act,
and Section 21E of the Exchange Act. All statements other than
statements of historical fact contained in this press release,
including statements regarding the benefits of the Proposed Damon
Transaction, the anticipated timing of the completion of the
Proposed Damon Transaction, the products under development by Damon
and the markets in which it plans to operate, the advantages of
Damon's technology, Damon's competitive landscape and positioning,
and Damon's growth plans and strategies, are forward-looking
statements. Some of these forward-looking statements can be
identified by the use of forward-looking words, including "may,"
"should," "expect," "intend," "will," "estimate," "anticipate,"
"believe," "predict," "plan," "targets," "projects," "could,"
"would," "continue," "forecast" or the negatives of these terms or
variations of them or similar expressions. All forward-looking
statements are subject to risks, uncertainties, and other factors
which could cause actual results to differ materially from those
expressed or implied by such forward-looking statements. All
forward-looking statements are based upon estimates, forecasts, and
assumptions that, while considered reasonable by Inpixon and its
management, and Damon and its management, as the case may be, are
inherently uncertain and many factors may cause the actual results
to differ materially from current expectations which include, but
are not limited to:
- the risk that the Proposed Damon Transaction may not be
completed in a timely manner or at all, which may adversely affect
the price of Inpixon's securities;
- the risk that the public market valuation of the combined
company following the consummation of the business combination may
differ from the valuation range ascertained by the parties to the
business combination and their respective financial advisors, and
that the valuation to be ascertained by an independent financial
advisor to Damon in connection with the business combination may
differ from the valuation ascertained by Inpixon's independent
financial advisor;
- the failure to satisfy the conditions to the consummation of
the Proposed Damon Transaction, including receiving the necessary
approvals from the Damon securityholders and the Supreme Court of
British Columbia with respect to
the Plan of Arrangement;
- the occurrence of any event, change or other circumstance that
could give rise to the termination of the Proposed Damon
Transaction;
- the effect of the announcement or pendency of the Proposed
Damon Transaction on Inpixon, Grafiti and Damon's business
relationships, performance, and business generally;
- risks that the Proposed Damon Transaction disrupts current
plans of Inpixon, Grafiti and Damon and potential difficulties in
their employee retention as a result of the Proposed Damon
Transaction;
- the outcome of any legal proceedings that may be instituted
against Damon, Grafiti or Inpixon related to the Proposed Damon
Transaction;
- failure to realize the anticipated benefits of the Proposed
Damon Transaction;
- the inability to satisfy the initial listing criteria of Nasdaq
or obtain Nasdaq approval of the initial listing of the combined
company on Nasdaq;
- the risk that the price of the securities of the combined
company may be volatile due to a variety of factors, including
changes in the highly competitive industries in which Grafiti and
Damon operate, variations in performance across competitors,
changes in laws, regulations, technologies that may impose
additional costs and compliance burdens on Grafiti and Damon's
operations, global supply chain disruptions and shortages, and
macro-economic and social environments affecting Grafiti and
Damon's business and changes in the combined capital
structure;
- the inability to implement business plans, forecasts, and other
expectations after the completion of the Proposed Damon
Transaction, and identify and realize additional
opportunities;
- the risk that Damon has a limited operating history, has not
achieved sufficient sales and production capacity at a
mass-production facility, and Damon and its current and future
collaborators may be unable to successfully develop and market
Damon's motorcycles or solutions, or may experience significant
delays in doing so;
- the risk that the combined company may never achieve or sustain
profitability;
- the risk that Damon and the combined company may be unable to
raise additional capital on acceptable terms to finance its
operations and remain a going concern;
- the risk that the combined company experiences difficulties in
managing its growth and expanding operations;
- the risk that Damon's $85 million
of non-binding reservations are canceled, modified, delayed or not
placed and that Damon must return the refundable deposits and such
reservations are not converted to sales;
- the risks relating to Damon's ability to satisfy the conditions
and deliver on the orders and reservations, its ability to maintain
quality control of its motorcycles, and Damon's dependence on third
parties for supplying components and manufacturing the
motorcycles;
- the risk that other motorcycle manufacturers develop
competitive electric motorcycles or other competitive motorcycles
that adversely affect Damon's market position;
- the risk that Damon's patent applications may not be approved
or may take longer than expected, and Damon may incur substantial
costs in enforcing and protecting its intellectual property;
- the risk that Damon's estimates of market demand may be
inaccurate; and
- other risks and uncertainties set forth in the sections
entitled "Risk Factors" and "Cautionary Note Regarding
Forward-Looking Statements" in Inpixon's Annual Report on Form 10-K
for the year ended December, 31, 2022, which was filed with the SEC
on April 17, 2023, and Quarterly
Report on Form 10-Q for the quarterly period thereafter, as such
factors may be updated from time to time in Inpixon's filings with
the SEC, and the registration statement to be filed by Grafiti in
connection with the Spin-off. These filings identify and address
other important risks and uncertainties that could cause actual
events and results to differ materially from those contained in the
forward-looking statements.
Nothing in this press release should be regarded as a
representation by any person that the forward-looking statements
set forth herein will be achieved or that any of the contemplated
results of such forward-looking statements will be achieved. You
should not place undue reliance on forward-looking statements,
which speak only as of the date they are made.
Neither Inpixon nor Damon gives any assurance
that either Inpixon or Damon or the combined company
will achieve its expected results. Neither Inpixon nor
Damon undertakes any duty to update these forward-looking
statements, except as otherwise required by law.
Important Information About the Proposed XTI Transaction and
Where to Find It
This press release, in part, relates to the previously announced
proposed transaction between XTI Aircraft, Inc. ("XTI") and Inpixon
pursuant to the agreement and plan of merger, dated as of
July 24, 2023, by and among Inpixon,
Superfly Merger Sub Inc. and XTI (the "Proposed XTI Transaction").
Inpixon filed a registration statement on Form S-4 with the U.S.
Securities and Exchange Commission on August
14, 2023, as amended by Amendment No. 1 on October 6, 2023 and Amendment No. 2 on
November 7, 2023, which included a
preliminary prospectus and proxy statement of Inpixon in connection
with the Proposed XTI Transaction, referred to as a proxy
statement/prospectus. The registration statement on Form S-4 became
effective as of November 13, 2023. A
proxy statement/prospectus will be delivered to all Inpixon
stockholders as of the applicable record date established for
voting on the transaction and to the stockholders of XTI. Inpixon
also will file other documents regarding the Proposed XTI
Transaction with the SEC.
Before making any voting decision, investors and security
holders are urged to read the registration statement, the proxy
statement/prospectus, any amendments thereto, and all other
relevant documents filed or that will be filed with the SEC in
connection with the Proposed XTI Transaction as they become
available because they will contain important information about
Inpixon, XTI and the Proposed XTI Transaction.
Investors and securityholders will be able to obtain free copies
of the registration statement, the proxy statement/prospectus and
all other relevant documents filed or that will be filed with the
SEC by Inpixon through the website maintained by the SEC at
www.sec.gov.
The documents filed by Inpixon with the SEC also may be obtained
free of charge at Inpixon's website at www.inpixon.com or upon
written request to: Inpixon, 2479 E. Bayshore Road, Suite 195,
Palo Alto, CA 94303.
NEITHER THE SEC NOR ANY STATE SECURITIES REGULATORY AGENCY HAS
APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED IN THIS
COMMUNICATION, PASSED UPON THE MERITS OR FAIRNESS OF THE
TRANSACTION OR RELATED TRANSACTIONS OR PASSED UPON THE ADEQUACY OR
ACCURACY OF THE DISCLOSURE IN THIS COMMUNICATION. ANY
REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE.
Forward-Looking Statements about the Proposed XTI
Transaction
This press release contains certain "forward-looking statements"
within the meaning of the United States Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act,
and Section 21E of the Exchange Act. All statements other than
statements of historical fact contained in this press release,
including statements regarding the benefits of the Proposed XTI
Transaction and the anticipated timing of the completion of the
Proposed XTI Transaction, are forward-looking statements.
Some of these forward-looking statements can be identified by
the use of forward-looking words, including "may," "should,"
"expect," "intend," "will," "estimate," "anticipate," "believe,"
"predict," "plan," "targets," "projects," "could," "would,"
"continue," "forecast" or the negatives of these terms or
variations of them or similar expressions. All forward-looking
statements are subject to risks, uncertainties, and other factors
which could cause actual results to differ materially from those
expressed or implied by such forward-looking statements. All
forward-looking statements are based upon estimates, forecasts, and
assumptions that, while considered reasonable by Inpixon and its
management, and XTI and its management, as the case may be, are
inherently uncertain and many factors may cause the actual results
to differ materially from current expectations which include, but
are not limited to:
- the risk that the Proposed XTI Transaction may not be completed
in a timely manner or at all, which may adversely affect the price
of Inpixon's securities;
- the failure to satisfy the conditions to the consummation of
the Proposed XTI Transaction, including the adoption of the merger
agreement by the shareholders of Inpixon;
- the occurrence of any event, change or other circumstance that
could give rise to the termination of the merger agreement;
- the adjustments permitted under the merger agreement to the
exchange ratio that could result in XTI shareholders or Inpixon
shareholders owning less of the post-combination company than
expected;
- the effect of the announcement or pendency of the Proposed XTI
Transaction on Inpixon's and XTI's business relationships,
performance, and business generally;
- the risks that the Proposed XTI Transaction disrupts current
plans of Inpixon and XTI and potential difficulties in Inpixon's
and XTI's employee retention because of the Proposed XTI
Transaction;
- the outcome of any legal proceedings that may be instituted
against XTI or against Inpixon related to the merger agreement or
the Proposed XTI Transaction;
- failure to realize the anticipated benefits of the Proposed XTI
Transaction;
- the inability to meet and maintain the listing of Inpixon's
securities (or the securities of the post-combination company) on
Nasdaq;
- the risk that the price of Inpixon's securities (or the
securities of the post-combination company) may be volatile due to
a variety of factors, including changes in the highly competitive
industries in which Inpixon and XTI operate;
- the inability to implement business plans, forecasts, and other
expectations after the completion of the Proposed XTI Transaction,
and identify and realize additional opportunities;
- variations in performance across competitors, changes in laws,
regulations, technologies that may impose additional costs and
compliance burdens on Inpixon and XTI's operations, global supply
chain disruptions and shortages;
- national security tensions, and macro-economic and social
environments affecting Inpixon and XTI's business and changes in
the combined capital structure;
- the risk that XTI has a limited operating history, has not yet
manufactured any non-prototype aircraft or delivered any aircraft
to a customer, and XTI and its current and future collaborators may
be unable to successfully develop and market XTI's aircraft or
solutions, or may experience significant delays in doing so;
- the risk that XTI is subject to the uncertainties associated
with the regulatory approvals of its aircraft including the
certification by the Federal Aviation Administration, which is a
lengthy and costly process;
- the risk that the post-combination company may never achieve or
sustain profitability;
- the risk that XTI, Inpixon and the post-combination company may
be unable to raise additional capital on acceptable terms to
finance its operations and remain a going concern;
- the risk that the post-combination company experiences
difficulties in managing its growth and expanding operations;
- the risk that XTI's conditional pre-orders (which include
conditional aircraft purchase agreements, non-binding reservations,
and options) are canceled, modified, delayed or not placed and that
XTI must return the refundable deposits;
- the risks relating to long development and sales cycles, XTI's
ability to satisfy the conditions and deliver on the orders and
reservations, its ability to maintain quality control of its
aircraft, and XTI's dependence on third parties for supplying
components and potentially manufacturing the aircraft;
- the risk that other aircraft manufacturers develop competitive
VTOL aircraft or other competitive aircraft that adversely affect
XTI's market position;
- the risk that XTI's future patent applications may not be
approved or may take longer than expected, and XTI may incur
substantial costs in enforcing and protecting its intellectual
property;
- the risk that XTI's estimates of market demand may be
inaccurate;
- the risk that XTI's ability to sell its aircraft may be limited
by circumstances beyond its control, such as a shortage of pilots
and mechanics who meet the training standards, high maintenance
frequencies and costs for the sold aircraft, and any accidents or
incidents involving VTOL aircraft that may harm customer
confidence; and
- other risks and uncertainties set forth in the sections
entitled "Risk Factors" and "Cautionary Note Regarding
Forward-Looking Statements" in Inpixon's Annual Report on Form 10-K
for the year ended December 31, 2022,
which was filed with the SEC on April 17,
2023 (the "2022 Form 10-K"), the Quarterly Report on Form
10-Q for the quarterly period filed thereafter, and the Current
Report on Form 8-K filed on July 25,
2023, and in the section entitled "Risk Factors" in XTI's
periodic reports filed pursuant to Regulation A of the Securities
Act including XTI's Annual Report on Form 1-K for the year ended
December 31, 2022, which was filed
with the SEC on July 13, 2023 (the
"2022 Form 1-K"), as such factors may be updated from time to time
in Inpixon's and XTI's filings with the SEC, the registration
statement on Form S-4 and the proxy statement/prospectus contained
therein. These filings identify and address other important risks
and uncertainties that could cause actual events and results to
differ materially from those contained in the forward-looking
statements.
Nothing in this press release should be regarded as a
representation by any person that the forward-looking statements
set forth herein will be achieved or that any of the contemplated
results of such forward-looking statements will be achieved. You
should not place undue reliance on forward-looking statements,
which speak only as of the date they are made. Neither Inpixon nor
XTI gives any assurance that either Inpixon or XTI or the
post-combination company will achieve its expected results. Neither
Inpixon nor XTI undertakes any duty to update these forward-looking
statements, except as otherwise required by law.
Participants in the Solicitation
XTI and Inpixon and their respective directors and officers and
other members of management may, under SEC rules, be deemed to be
participants in the solicitation of proxies from Inpixon's
stockholders with the Proposed XTI Transaction and the other
matters set forth in the registration statement. Information about
Inpixon's and XTI's directors and executive officers is set forth
in Inpixon's filings and XTI's filings with the SEC, including
Inpixon's 2022 Form 10-K and XTI's 2022 Form 1-K. Additional
information regarding the direct and indirect interests, by
security holdings or otherwise, of those persons and other persons
who may be deemed participants in the Proposed XTI Transaction may
be obtained by reading the proxy statement/prospectus regarding the
Proposed XTI Transaction when it becomes available. You may obtain
free copies of these documents as described above under "Important
Information About the Proposed Transaction and Where to Find
It."
No Offer or Solicitation
This press release is not a proxy statement or solicitation of a
proxy, consent or authorization with respect to any securities or
in respect of the proposed transactions and is not intended to and
does not constitute an offer to sell or the solicitation of an
offer to buy, sell or solicit any securities or any proxy, vote or
approval, nor shall there be any sale of securities in any
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such jurisdiction. No offer of securities
shall be deemed to be made except by means of a prospectus meeting
the requirements of Section 10 of the Securities Act.
Contacts
Inpixon Contacts
General
inquiries:
Email: marketing@inpixon.com
Web: inpixon.com/contact-us
Investor relations:
Crescendo Communications for Inpixon
Tel: +1 212-671-1020
Email: INPX@crescendo-ir.com
XTI Aircraft Contacts
General
inquiries:
Email: liftup@xtiaircraft.com
Web: xtiaircraft.com/cm/get-involved
Investor relations:
Crescendo Communications for
XTI
Tel: +1 212-671-1020
Email: XTI@crescendo-ir.com
INPIXON AND
SUBSIDIARIES
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
(In thousands,
except number of shares and par value data)
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
September 30,
2023
|
|
December 31,
2022
|
|
|
(Unaudited)
|
|
(Audited)
|
ASSETS
|
|
|
|
|
Current
Assets
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
13,489
|
|
$
|
10,235
|
Accounts receivable,
net of allowance for credit losses of $237 and $272,
respectively
|
|
|
1,560
|
|
|
1,889
|
Other
receivables
|
|
|
142
|
|
|
86
|
Inventory
|
|
|
3,355
|
|
|
2,442
|
Notes
receivable
|
|
|
2,068
|
|
|
150
|
Prepaid assets and
other current assets
|
|
|
1,949
|
|
|
2,803
|
Current assets of discontinued operations
|
|
|
--
|
|
|
12,261
|
Total Current
Assets
|
|
|
22,563
|
|
|
29,866
|
|
|
|
|
|
|
|
Property and equipment,
net
|
|
|
1,013
|
|
|
1,064
|
Operating lease
right-of-use asset, net
|
|
|
376
|
|
|
531
|
Software development
costs, net
|
|
|
988
|
|
|
1,265
|
Investment in equity
securities
|
|
|
189
|
|
|
330
|
Long-term
investments
|
|
|
50
|
|
|
716
|
Intangible assets,
net
|
|
|
2,304
|
|
|
2,994
|
Other assets
|
|
|
164
|
|
|
158
|
Non-current assets of
discontinued operations
|
|
|
--
|
|
|
20,711
|
Total
Assets
|
|
$
|
27,647
|
|
$
|
57,635
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
Current
Liabilities
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
1,920
|
|
$
|
1,503
|
Accrued
liabilities
|
|
|
3,569
|
|
|
2,619
|
Warrant
Liability
|
|
|
1,410
|
|
|
--
|
Operating lease
obligation, current
|
|
|
198
|
|
|
211
|
Deferred
revenue
|
|
|
1,315
|
|
|
1,323
|
Short-term
debt
|
|
|
11,165
|
|
|
13,643
|
Acquisition
liability
|
|
|
--
|
|
|
197
|
Current liabilities of
discontinued operations
|
|
|
--
|
|
|
5,218
|
Total Current
Liabilities
|
|
|
19,577
|
|
|
24,714
|
|
|
|
|
|
|
|
Long Term
Liabilities
|
|
|
|
|
|
|
Operating lease
obligations, noncurrent
|
|
|
188
|
|
|
334
|
Non-current liabilities
of discontinued operations
|
|
|
--
|
|
|
472
|
Total
Liabilities
|
|
|
19,765
|
|
|
25,520
|
|
|
|
|
|
|
|
Commitments and
Contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
Equity
|
|
|
|
|
|
|
Preferred Stock -
$0.001 par value; 5,000,000 shares authorized.
|
|
|
|
|
|
|
Series 4 Convertible
Preferred Stock - 10,415 shares authorized; 1 issued and 1
outstanding as of September 30, 2023 and December 31, 2022,
respectively;
|
|
|
--
|
|
|
--
|
Series 5 Convertible
Preferred Stock - 12,000 shares authorized; 126 issued and 126
outstanding as of September 30, 2023 and December 31, 2022,
respectively.
|
|
|
--
|
|
|
--
|
Common Stock - $0.001
par value; 500,000,000 shares authorized; 111,692,178 and 3,570,894
issued and 111,692,177 and 3,570,893 outstanding as of September
30, 2023 and December 31, 2022, respectively.
|
|
|
112
|
|
|
4
|
Additional paid-in
capital
|
|
|
358,692
|
|
|
346,668
|
Treasury stock, at
cost, 1 share
|
|
|
(695)
|
|
|
(695)
|
Accumulated other
comprehensive income
|
|
|
41
|
|
|
1,061
|
Accumulated
deficit
|
|
|
(347,971)
|
|
|
(313,739)
|
Stockholders' Equity
Attributable to Inpixon
|
|
|
10,179
|
|
|
33,299
|
|
|
|
|
|
|
|
Non-controlling
interest
|
|
|
(2,297)
|
|
|
(1,184)
|
|
|
|
|
|
|
|
Total Stockholders'
Equity
|
|
|
7,882
|
|
|
32,115
|
|
|
|
|
|
|
|
Total Liabilities
and Stockholders' Equity
|
|
$
|
27,647
|
|
$
|
57,635
|
INPIXON AND
SUBSIDIARIES
|
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS
|
(In thousands,
except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended
|
|
|
For the Nine Months
Ended
|
|
|
September
30,
|
|
|
September
30,
|
|
|
2023
|
|
2022
|
|
|
2023
|
|
2022
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
2,016
|
|
$
|
2,435
|
|
|
$
|
7,177
|
|
$
|
7,660
|
Cost of
Revenues
|
|
|
451
|
|
|
756
|
|
|
|
1,632
|
|
|
2,409
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit
|
|
|
1,565
|
|
|
1,679
|
|
|
|
5,545
|
|
|
5,251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development
|
|
|
2,347
|
|
|
2,136
|
|
|
|
6,380
|
|
|
6,713
|
Sales and
marketing
|
|
|
1,149
|
|
|
1,036
|
|
|
|
3,506
|
|
|
2,960
|
General and
administrative
|
|
|
3,747
|
|
|
3,573
|
|
|
|
13,596
|
|
|
12,705
|
Acquisition related
costs
|
|
|
1,656
|
|
|
2
|
|
|
|
2,343
|
|
|
254
|
Transaction
costs
|
|
|
1,527
|
|
|
--
|
|
|
|
2,970
|
|
|
--
|
Impairment of
goodwill
|
|
|
--
|
|
|
--
|
|
|
|
--
|
|
|
2,030
|
Amortization of
intangibles
|
|
|
221
|
|
|
395
|
|
|
|
671
|
|
|
1,137
|
Total Operating
Expenses
|
|
|
10,647
|
|
|
7,142
|
|
|
|
29,466
|
|
|
25,799
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from
Operations
|
|
|
(9,082)
|
|
|
(5,463)
|
|
|
|
(23,921)
|
|
|
(20,548)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
(Expense)/Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense,
net
|
|
|
(818)
|
|
|
(234)
|
|
|
|
(4,300)
|
|
|
(65)
|
Other income/(expense),
net
|
|
|
(44)
|
|
|
830
|
|
|
|
1,169
|
|
|
802
|
Unrealized gain/(loss)
on equity securities
|
|
|
5,791
|
|
|
(5,854)
|
|
|
|
5,733
|
|
|
(7,110)
|
Realized loss on equity
securities
|
|
|
(6,692)
|
|
|
(151)
|
|
|
|
(6,692)
|
|
|
(151)
|
Total Other
Expense
|
|
|
(1,763)
|
|
|
(5,409)
|
|
|
|
(4,090)
|
|
|
(6,524)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss from
Continuing Operations, before tax
|
|
|
(10,845)
|
|
|
(10,872)
|
|
|
|
(28,011)
|
|
|
(27,072)
|
Income tax
provision
|
|
|
(3)
|
|
|
--
|
|
|
|
(2,488)
|
|
|
(22)
|
Net Loss from
Continuing Operations
|
|
|
(10,848)
|
|
|
(10,872)
|
|
|
|
(30,499)
|
|
|
(27,094)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from Discontinued
Operations, Net of Tax
|
|
|
--
|
|
|
(7,121)
|
|
|
|
(4,856)
|
|
|
(22,786)
|
Net
Loss
|
|
|
(10,848)
|
|
|
(17,993)
|
|
|
|
(35,355)
|
|
|
(49,880)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
Attributable to Non-controlling Interest
|
|
|
(464)
|
|
|
(402)
|
|
|
|
(1,131)
|
|
|
(1,206)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
Attributable to Stockholders of Inpixon
|
|
|
(10,384)
|
|
|
(17,591)
|
|
|
|
(34,224)
|
|
|
(48,674)
|
Accretion of Series 7
preferred stock
|
|
|
--
|
|
|
--
|
|
|
|
--
|
|
|
(4,555)
|
Accretion of Series 8
Preferred Stock
|
|
|
--
|
|
|
(6,305)
|
|
|
|
--
|
|
|
(13,089)
|
Deemed dividend for the
modification related to Series 8 Preferred Stock
|
|
|
--
|
|
|
--
|
|
|
|
--
|
|
|
(2,627)
|
Deemed contribution for
the modification related to Warrants issued in connection with
Series 8 Preferred Stock
|
|
|
--
|
|
|
--
|
|
|
|
--
|
|
|
1,469
|
Amortization premium -
modification related to Series 8 Preferred Stock
|
|
|
--
|
|
|
1,265
|
|
|
|
--
|
|
|
2,626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
Attributable to Common Stockholders
|
|
$
|
(10,384)
|
|
$
|
(22,631)
|
|
|
$
|
(34,224)
|
|
$
|
(64,850)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss Per Share -
Basic and Diluted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing
Operations
|
|
$
|
(0.16)
|
|
$
|
(7.00)
|
|
|
$
|
(0.82)
|
|
$
|
(20.16)
|
Discontinued Operations
|
|
$
|
--
|
|
$
|
(3.21)
|
|
|
$
|
(0.14)
|
|
$
|
(10.92)
|
Net Loss Per Share -
Basic and Diluted
|
|
$
|
(0.16)
|
|
$
|
(10.21)
|
|
|
$
|
(0.96)
|
|
$
|
(31.08)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
Shares Outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and
Diluted
|
|
|
65,840,189
|
|
|
2,216,544
|
|
|
|
35,845,916
|
|
|
2,086,633
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive
Loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
$
|
(10,848)
|
|
$
|
(17,993)
|
|
|
$
|
(35,355)
|
|
$
|
(49,880)
|
Unrealized gain on
available for sale debt securities
|
|
|
--
|
|
|
(375)
|
|
|
|
--
|
|
|
--
|
Unrealized foreign
exchange gain (loss) from cumulative translation
adjustments
|
|
|
230
|
|
|
1,273
|
|
|
|
(1,020)
|
|
|
1,452
|
Comprehensive
Loss
|
|
$
|
(10,618)
|
|
$
|
(17,095)
|
|
|
$
|
(36,375)
|
|
$
|
(48,428)
|
INPIXON AND
SUBSIDIARIES
|
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
(In
thousands)
|
|
|
|
|
|
|
|
|
|
For the Nine Months
Ended
|
|
|
September
30,
|
|
|
2023
|
|
2022
|
(Unaudited)
|
Cash Flows Used In
Operating Activities
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(35,355)
|
|
$
|
(49,880)
|
Adjustments to
reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
834
|
|
|
1,008
|
Amortization of
intangible assets
|
|
|
1,476
|
|
|
4,559
|
Amortization of right
of use asset
|
|
|
206
|
|
|
536
|
Stock based
compensation
|
|
|
797
|
|
|
2,962
|
Amortization of warrant
liability to redemption value
|
|
|
20
|
|
|
--
|
Earnout expense
valuation benefit
|
|
|
--
|
|
|
(2,827)
|
Gain on settlement with
FOXO
|
|
|
(1,142)
|
|
|
--
|
Amortization of debt
issuance costs
|
|
|
2,103
|
|
|
121
|
Accrued interest
income, related party
|
|
|
--
|
|
|
(278)
|
Unrealized gain on
note
|
|
|
--
|
|
|
1,870
|
Unrealized loss on
foreign currency transactions
|
|
|
176
|
|
|
--
|
Distribution of equity
method investment shares to employees as compensation
|
|
|
666
|
|
|
--
|
Deferred income
tax
|
|
|
2,591
|
|
|
(1)
|
Unrealized (gain) loss
on equity securities
|
|
|
(5,733)
|
|
|
7,110
|
Impairment of
goodwill
|
|
|
--
|
|
|
7,570
|
Gain on fair value of
warrant liability
|
|
|
71
|
|
|
--
|
Realized loss on sale
of equity securities
|
|
|
6,692
|
|
|
151
|
Gain on conversion of
note receivable
|
|
|
--
|
|
|
(791)
|
Loss on exchange of
debt for equity
|
|
|
124
|
|
|
--
|
Other
|
|
|
24
|
|
|
202
|
|
|
|
|
|
|
|
Changes in operating
assets and liabilities:
|
|
|
|
|
|
|
Accounts receivable and
other receivables
|
|
|
(652)
|
|
|
336
|
Inventory
|
|
|
(951)
|
|
|
(1,002)
|
Prepaid expenses and
other current assets
|
|
|
1,110
|
|
|
1,545
|
Other assets
|
|
|
3
|
|
|
28
|
Accounts
payable
|
|
|
(372)
|
|
|
237
|
Accrued
liabilities
|
|
|
2,018
|
|
|
1,059
|
Income tax
liabilities
|
|
|
(119)
|
|
|
(38)
|
Deferred
revenue
|
|
|
530
|
|
|
(915)
|
Operating lease
obligation
|
|
|
(207)
|
|
|
(505)
|
Net Cash Used in
Operating Activities
|
|
$
|
(25,090)
|
|
$
|
(26,943)
|
|
|
|
|
|
|
|
Cash Flows Used in
Investing Activities
|
|
|
|
|
|
|
Purchase
of property and equipment
|
|
|
(142)
|
|
|
(221)
|
Investment in
capitalized software
|
|
|
(135)
|
|
|
(611)
|
Purchase of convertible
note
|
|
|
--
|
|
|
(5,500)
|
Sales of equity
securities
|
|
|
323
|
|
|
229
|
Sales of treasury
bills
|
|
|
--
|
|
|
43,001
|
Proceeds from repayment
of note receivable
|
|
|
150
|
|
|
--
|
Issuance of note
receivable
|
|
|
(2,025)
|
|
|
(150)
|
Net Cash (Used in)
Provided By Investing Activities
|
|
$
|
(1,829)
|
|
$
|
36,748
|
|
|
|
|
|
|
|
Cash From Financing
Activities
|
|
|
|
|
|
|
Net proceeds from
issuance of preferred stock
|
|
$
|
--
|
|
|
46,906
|
Net proceeds from
promissory note
|
|
|
125
|
|
|
5,539
|
Net proceeds from ATM
stock offerings
|
|
|
26,510
|
|
|
--
|
Cash paid for
redemption of preferred stock series 7
|
|
|
--
|
|
|
(49,250)
|
Taxes paid related to
net share settlement of restricted stock units
|
|
|
--
|
|
|
(336)
|
Net proceeds from
issuance of warrants
|
|
|
1,409
|
|
|
--
|
Repayment of CXApp
acquisition liability
|
|
|
(197)
|
|
|
(1,957)
|
Distribution to
shareholders related to spin-off of CXApp
|
|
|
(10,003)
|
|
|
--
|
Common shares issued
for net proceeds from warrants
|
|
|
2,341
|
|
|
--
|
Net Cash Provided By
Financing Activities
|
|
$
|
20,185
|
|
$
|
902
|
|
|
|
|
|
|
|
Effect of Foreign
Exchange Rate on Changes on Cash
|
|
|
(12)
|
|
|
(34)
|
|
|
|
|
|
|
|
Net (Decrease)
Increase in Cash and Cash Equivalents
|
|
|
(6,746)
|
|
|
10,673
|
|
|
|
|
|
|
|
Cash and Cash
Equivalents - Beginning of year
|
|
|
20,235
|
|
|
52,480
|
|
|
|
|
|
|
|
Cash and Cash
Equivalents - End of year
|
|
$
|
13,489
|
|
$
|
63,153
|
Reconciliation of
Non-GAAP Financial Measures:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended
|
|
For the Nine Months
Ended
|
(In
thousands)
|
|
September
30,
|
|
September
30,
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
|
|
|
|
|
|
|
|
|
Net loss attributable
to common stockholders
|
|
$
(10,384)
|
|
$ (22,631)
|
|
$
(34,224)
|
|
$
(64,850)
|
Loss
from discontinued operations, net of tax
|
|
-
|
|
7,121
|
|
4,856
|
|
22,786
|
Interest expense,
net
|
|
818
|
|
234
|
|
4,300
|
|
65
|
Income tax
provision
|
|
3
|
|
-
|
|
2,488
|
|
22
|
Depreciation and
amortization
|
|
433
|
|
705
|
|
1,277
|
|
2,123
|
EBITDA
|
|
(9,130)
|
|
(14,571)
|
|
(21,303)
|
|
(39,854)
|
Adjusted
for:
|
|
|
|
|
|
|
|
|
Non-recurring one-time
charges:
|
|
|
|
|
|
|
|
|
Unrealized (gain)/loss
on equity securities
|
|
(5,791)
|
|
5,854
|
|
(5,733)
|
|
7,110
|
Realized loss on
equity securities
|
|
6,692
|
|
151
|
|
6,692
|
|
151
|
Unrealized gain on
note
|
|
-
|
|
153
|
|
-
|
|
325
|
Acquisition
transaction/financing costs
|
|
1,656
|
|
2
|
|
2,343
|
|
254
|
Professional service
fees
|
|
-
|
|
-
|
|
-
|
|
8
|
Impairment of
goodwill
|
|
-
|
|
-
|
|
-
|
|
2,030
|
Transaction costs
|
|
1,527
|
|
-
|
|
2,970
|
|
-
|
Accretion of series 7
preferred stock
|
|
-
|
|
-
|
|
-
|
|
4,555
|
Accretion of series 8
preferred stock
|
|
-
|
|
6,305
|
|
-
|
|
13,089
|
Deemed dividend for the
modification related to Series 8 preferred stock
|
|
-
|
|
-
|
|
-
|
|
2,627
|
Deemed contribution for the modification related to
warrants issued in connection with the Series 8 Preferred
Stock
|
|
-
|
|
-
|
|
-
|
|
(1,469)
|
Amortization premium -
modification to Series 8 preferred stock
|
|
-
|
|
(1,265)
|
|
-
|
|
(2,626)
|
Distribution of
equity method investment shares to employees as
compensation
|
|
-
|
|
-
|
|
666
|
|
-
|
Gain on equity
securities
|
|
-
|
|
-
|
|
(1,142)
|
|
-
|
Loss on exchange of
debt for equity
|
|
124
|
|
-
|
|
124
|
|
-
|
Unrealized foreign
exchange losses
|
|
354
|
|
1,019
|
|
209
|
|
1,143
|
Bad debts
expense/provision
|
|
-
|
|
-
|
|
24
|
|
-
|
Reserve for inventory obsolescence
|
|
(8)
|
|
-
|
|
8
|
|
-
|
Stock-based
compensation – compensation and related benefits
|
|
227
|
|
688
|
|
797
|
|
2,962
|
Severance
costs
|
|
244
|
|
239
|
|
371
|
|
301
|
Adjusted
EBITDA
|
|
$ (4,105)
|
|
$
(1,425)
|
|
$
(13,974)
|
|
$
(9,394)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended
|
|
For the Nine Months
Ended
|
(In thousands, except
share data)
|
|
September
30,
|
|
September
30,
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
|
|
|
|
|
|
|
|
|
Net loss attributable
to common stockholders
|
|
$
(10,384)
|
|
$ (22,631)
|
|
$
(34,224)
|
|
$
(64,850)
|
Adjustments:
|
|
|
|
|
|
|
|
|
Non-recurring one-time
charges:
|
|
|
|
|
|
|
|
|
Loss
from discontinued operations, net of tax
|
|
-
|
|
7,121
|
|
4,856
|
|
22,786
|
Unrealized (gain)/loss
on equity securities
|
|
(5,791)
|
|
5,854
|
|
(5,733)
|
|
7,110
|
Realized loss on
equity securities
|
|
6,692
|
|
151
|
|
6,692
|
|
151
|
Unrealized gain on
note
|
|
-
|
|
153
|
|
-
|
|
325
|
Acquisition
transaction/financing costs
|
|
1,656
|
|
2
|
|
2,343
|
|
254
|
Professional service
fees
|
|
-
|
|
-
|
|
-
|
|
8
|
Impairment of
goodwill
|
|
-
|
|
-
|
|
-
|
|
2,030
|
Transaction costs
|
|
1,527
|
|
-
|
|
2,970
|
|
-
|
Accretion of series 7
preferred stock
|
|
-
|
|
-
|
|
-
|
|
4,555
|
Accretion of series 8
preferred stock
|
|
-
|
|
6,305
|
|
-
|
|
13,089
|
Deemed dividend for the
modification Series 8 preferred stock
|
|
-
|
|
-
|
|
-
|
|
2,627
|
Deemed contribution for the
modification related to warrants issued in connection with the
Series 8 Preferred Stock
|
|
-
|
|
-
|
|
-
|
|
(1,469)
|
Amortization premium -
modification to Series 8 preferred stock
|
|
-
|
|
(1,265)
|
|
-
|
|
(2,626)
|
Distribution of equity method investment shares to employees as
compensation
|
|
-
|
|
-
|
|
666
|
|
-
|
Gain on equity
securities
|
|
-
|
|
-
|
|
(1,142)
|
|
-
|
Loss on exchange of
debt for equity
|
|
124
|
|
-
|
|
124
|
|
-
|
Unrealized foreign
exchange losses
|
|
354
|
|
1,019
|
|
209
|
|
1,143
|
Bad debts
expense/provision
|
|
-
|
|
-
|
|
24
|
|
-
|
Reserve for inventory
obsolescence
|
|
(8)
|
|
-
|
|
8
|
|
-
|
Stock-based
compensation - compensation and related benefits
|
|
227
|
|
688
|
|
797
|
|
2,962
|
Severance
costs
|
|
244
|
|
239
|
|
371
|
|
301
|
Amortization of
intangibles
|
|
221
|
|
511
|
|
671
|
|
1,640
|
Proforma non-GAAP net
loss
|
|
$ (5,138)
|
|
$
(1,853)
|
|
$
(21,368)
|
|
$
(9,964)
|
Proforma non-GAAP net
loss per common share - basic and diluted
|
|
$
(0.08)
|
|
$
(0.84)
|
|
$
(0.60)
|
|
$ (4.78)
|
Weighted average basic
and diluted common shares outstanding
|
|
65,840,189
|
|
2,216,544
|
|
35,845,916
|
|
2,086,633
|
|
|
|
|
|
|
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inpixon-reports-third-quarter-2023-financial-results-and-provides-business-update-301988043.html
SOURCE Inpixon